These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 2270988)

  • 1. [The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)].
    Probatova NA
    Arkh Patol; 1990; 52(9):72-5. PubMed ID: 2270988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [R.E.A.L. classification of non-Hodgkin lymphoma from the clinico-oncologic viewpoint].
    Meusers P; Brittinger G
    Praxis (Bern 1994); 1998 Jun; 87(23):793-800. PubMed ID: 9654985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fas ligand expression in nodal non-Hodgkin's lymphoma.
    Müllauer L; Mosberger I; Chott A
    Mod Pathol; 1998 Apr; 11(4):369-75. PubMed ID: 9578088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Paraneoplastic lymphadenopathy].
    Melikian AL; Nikitin EA; Kaplanskaia IB; Frank GA
    Ter Arkh; 2007; 79(8):44-52. PubMed ID: 17926471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD95 antigen and Bcl-2 protein in non-Hodgkin's lymphomas and Hodgkin's disease.
    Nguyen PL; Harris NL; Ritz J; Robertson MJ
    Am J Pathol; 1996 Mar; 148(3):847-53. PubMed ID: 8774139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Practical value of the histopathological diagnosis of malignant lymphomas].
    Bryon PA
    Rev Prat; 1993 Sep; 43(13):1617-23. PubMed ID: 8303176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The results of histological and immunohistological studies of primary biopsies in 400 patients with non-Hodgkin's lymphoma in the North-West region of Russia (according to WHO classification)].
    Krivolapov IuA
    Ter Arkh; 2004; 76(7):64-70. PubMed ID: 15379131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential expression of the mucosal homing receptor integrin alpha 4 beta 7 in gastrointestinal non-Hodgkin's lymphomas.
    Drillenburg P; van der Voort R; Koopman G; Dragosics B; van Krieken JH; Kluin P; Meenan J; Lazarovits AI; Radaszkiewicz T; Pals ST
    Am J Pathol; 1997 Mar; 150(3):919-27. PubMed ID: 9060830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nodal monocytoid B-cell lymphoma (nodal marginal-zone B-cell lymphoma).
    Nathwani BN; Drachenberg MR; Hernandez AM; Levine AM; Sheibani K
    Semin Hematol; 1999 Apr; 36(2):128-38. PubMed ID: 10319381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Malignant lymphoma with medium-sized macronucleolated cells in the dog: involvement of an original cell from the marginal zone of the reactive lymph node].
    Magnol JP; Fournel C; Marchal T; Chabanne L; Bryon PA; Felman P
    Bull Acad Natl Med; 1995 Jan; 179(1):51-65. PubMed ID: 7788447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New REAL clinical entities.
    Fisher RI; Miller TP; Grogan TM
    Cancer J Sci Am; 1998 Jul; 4 Suppl 2():S5-12. PubMed ID: 9672769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraffin-immunohistochemical analysis of 226 non-Hodgkin's malignant lymphomas in the endemic area of human T-cell leukemia virus type 1.
    Hasui K
    Acta Pathol Jpn; 1991 May; 41(5):350-62. PubMed ID: 1867099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD40 ligand is constitutively expressed in a subset of T cell lymphomas and on the microenvironmental reactive T cells of follicular lymphomas and Hodgkin's disease.
    Carbone A; Gloghini A; Gruss HJ; Pinto A
    Am J Pathol; 1995 Oct; 147(4):912-22. PubMed ID: 7573367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
    Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
    J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A morphological study of 608 cases of canine malignant lymphoma in France with a focus on comparative similarities between canine and human lymphoma morphology.
    Ponce F; Marchal T; Magnol JP; Turinelli V; Ledieu D; Bonnefont C; Pastor M; Delignette ML; Fournel-Fleury C
    Vet Pathol; 2010 May; 47(3):414-33. PubMed ID: 20472804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary non-Hodgkin lymphomas of the CNS. Classification, tissue reaction and proliferative activity.
    Bergmann M; Kuchelmeister K; Edel G; Heinecke A
    Zentralbl Pathol; 1993 Mar; 139(1):37-44. PubMed ID: 8098955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological markers in non-Hodgkin's lymphomas.
    Gobbi M; Mazza P; Mantovani W; Fiacchini M; Lauria F; Tura S
    Boll Ist Sieroter Milan; 1979 Nov; 58(5):410-5. PubMed ID: 399843
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
    Kalyan K; Basu D; Soundararaghavan J
    Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosomal abnormalities and molecular genetics of non-Hodgkin's lymphoma.
    Ong ST; Le Beau MM
    Semin Oncol; 1998 Aug; 25(4):447-60. PubMed ID: 9728595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytologic and immunocytologic studies of peripheral T-cell lymphomas.
    Oertel J; Oertel B; Lobeck H; Huhn D
    Acta Cytol; 1991; 35(3):285-93. PubMed ID: 2042431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.